Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Research Report 2021

Publisher Name :
Date: 19-Feb-2021
No. of pages: 94
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Nesina

- Tradjenta

- Onglyza

- Januvia

- Others

Segment by Application

- Type 2 Diabetes

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Sanofi

- Takeda

- Eli Lilly

- Merck

- Novo Nordisk

- Bristol-Myers Squibb

- Pfizer

- AstraZeneca

- GlaxoSmithKline

- Boehringer Ingelheim

Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Research Report 2021

Table of Contents
1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Overview
1.1 Product Overview and Scope of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
1.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Type
1.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Nesina
1.2.3 Tradjenta
1.2.4 Onglyza
1.2.5 Januvia
1.2.6 Others
1.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Application
1.3.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Comparison by Application: (2021-2027)
1.3.2 Type 2 Diabetes
1.3.3 Others
1.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size Estimates and Forecasts
1.4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue 2016-2027
1.4.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales 2016-2027
1.4.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Region: 2016 Versus 2021 Versus 2027
2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Competition by Manufacturers
2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Manufacturers (2016-2021)
2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Sites, Area Served, Product Type
2.5 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Competitive Situation and Trends
2.5.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Players Market Share by Revenue
2.5.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Retrospective Market Scenario by Region
3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Facts & Figures by Country
3.3.1 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country
3.3.2 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Facts & Figures by Country
3.4.1 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country
3.4.2 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Facts & Figures by Region
3.5.1 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region
3.5.2 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Facts & Figures by Country
3.6.1 Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country
3.6.2 Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Facts & Figures by Country
3.7.1 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country
3.7.2 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Historic Market Analysis by Type
4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2016-2021)
4.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Type (2016-2021)
4.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Type (2016-2021)
5 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Historic Market Analysis by Application
5.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2016-2021)
5.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Application (2016-2021)
5.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Sanofi Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Takeda
6.2.1 Takeda Corporation Information
6.2.2 Takeda Description and Business Overview
6.2.3 Takeda Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Takeda Product Portfolio
6.2.5 Takeda Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Eli Lilly Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Merck Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Novo Nordisk
6.5.1 Novo Nordisk Corporation Information
6.5.2 Novo Nordisk Description and Business Overview
6.5.3 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Novo Nordisk Product Portfolio
6.5.5 Novo Nordisk Recent Developments/Updates
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Bristol-Myers Squibb Product Portfolio
6.6.5 Bristol-Myers Squibb Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Pfizer Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.8.4 AstraZeneca Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 GlaxoSmithKline
6.9.1 GlaxoSmithKline Corporation Information
6.9.2 GlaxoSmithKline Description and Business Overview
6.9.3 GlaxoSmithKline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.9.4 GlaxoSmithKline Product Portfolio
6.9.5 GlaxoSmithKline Recent Developments/Updates
6.10 Boehringer Ingelheim
6.10.1 Boehringer Ingelheim Corporation Information
6.10.2 Boehringer Ingelheim Description and Business Overview
6.10.3 Boehringer Ingelheim Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Boehringer Ingelheim Product Portfolio
6.10.5 Boehringer Ingelheim Recent Developments/Updates
7 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Cost Analysis
7.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
7.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Distributors List
8.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Customers
9 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Dynamics
9.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Trends
9.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Growth Drivers
9.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Challenges
9.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Restraints
10 Global Market Forecast
10.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Type (2022-2027)
10.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Application (2022-2027)
10.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Covered in This Study
Table 5. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Manufacturers (2016-2021)
Table 7. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Sites and Area Served
Table 11. Manufacturers Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Type
Table 12. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dipeptidyl Peptidase-4 (DPP-4) Inhibitors as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2016-2021) & (K MT)
Table 16. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region (2016-2021)
Table 17. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2016-2021) & (K MT)
Table 19. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2016-2021)
Table 20. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country (2016-2021)
Table 22. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2016-2021) & (K MT)
Table 23. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2016-2021)
Table 24. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region (2016-2021)
Table 30. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2016-2021)
Table 32. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country (2016-2021)
Table 38. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT) by Type (2016-2021)
Table 39. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2016-2021)
Table 40. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Million US$) by Type (2016-2021)
Table 41. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Type (2016-2021)
Table 42. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price (USD/MT) by Type (2016-2021)
Table 43. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT) by Application (2016-2021)
Table 44. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2016-2021)
Table 45. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Million US$) by Application (2016-2021)
Table 46. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Application (2016-2021)
Table 47. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price (USD/MT) by Application (2016-2021)
Table 48. Sanofi Corporation Information
Table 49. Sanofi Description and Business Overview
Table 50. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product
Table 52. Sanofi Recent Developments/Updates
Table 53. Takeda Corporation Information
Table 54. Takeda Description and Business Overview
Table 55. Takeda Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Takeda Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product
Table 57. Takeda Recent Developments/Updates
Table 58. Eli Lilly Corporation Information
Table 59. Eli Lilly Description and Business Overview
Table 60. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product
Table 62. Eli Lilly Recent Developments/Updates
Table 63. Merck Corporation Information
Table 64. Merck Description and Business Overview
Table 65. Merck Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Merck Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product
Table 67. Merck Recent Developments/Updates
Table 68. Novo Nordisk Corporation Information
Table 69. Novo Nordisk Description and Business Overview
Table 70. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product
Table 72. Novo Nordisk Recent Developments/Updates
Table 73. Bristol-Myers Squibb Corporation Information
Table 74. Bristol-Myers Squibb Description and Business Overview
Table 75. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product
Table 77. Bristol-Myers Squibb Recent Developments/Updates
Table 78. Pfizer Corporation Information
Table 79. Pfizer Description and Business Overview
Table 80. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product
Table 82. Pfizer Recent Developments/Updates
Table 83. AstraZeneca Corporation Information
Table 84. AstraZeneca Description and Business Overview
Table 85. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product
Table 87. AstraZeneca Recent Developments/Updates
Table 88. GlaxoSmithKline Corporation Information
Table 89. GlaxoSmithKline Description and Business Overview
Table 90. GlaxoSmithKline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. GlaxoSmithKline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product
Table 92. GlaxoSmithKline Recent Developments/Updates
Table 93. Boehringer Ingelheim Corporation Information
Table 94. Boehringer Ingelheim Description and Business Overview
Table 95. Boehringer Ingelheim Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Boehringer Ingelheim Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product
Table 97. Boehringer Ingelheim Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Distributors List
Table 101. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Customers List
Table 102. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Trends
Table 103. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Growth Drivers
Table 104. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Restraints
Table 105. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Type (2022-2027) & (K MT)
Table 106. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share Forecast by Type (2022-2027)
Table 107. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 108. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share Forecast by Type (2022-2027)
Table 109. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Application (2022-2027) & (K MT)
Table 110. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share Forecast by Application (2022-2027)
Table 111. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 112. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share Forecast by Application (2022-2027)
Table 113. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Region (2022-2027) & (K MT)
Table 114. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share Forecast by Region (2022-2027)
Table 115. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 116. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share Forecast by Region (2022-2027)
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
Figure 2. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share by Type in 2020 & 2027
Figure 3. Nesina Product Picture
Figure 4. Tradjenta Product Picture
Figure 5. Onglyza Product Picture
Figure 6. Januvia Product Picture
Figure 7. Others Product Picture
Figure 8. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share by Application in 2020 & 2027
Figure 9. Type 2 Diabetes
Figure 10. Others
Figure 11. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size 2016-2027 (US$ Million)
Figure 13. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales 2016-2027 (K MT)
Figure 14. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Manufacturers in 2020
Figure 16. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Players: Market Share by Revenue in 2020
Figure 18. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region (2016-2021)
Figure 20. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region in 2020
Figure 21. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region (2016-2021)
Figure 22. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region in 2020
Figure 23. U.S. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Type (2016-2021)
Figure 48. Sales Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Application (2016-2021)
Figure 49. Sales Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Application in 2020
Figure 50. Revenue Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Application (2016-2021)
Figure 51. Revenue Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Application in 2020
Figure 52. Manufacturing Cost Structure of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
Figure 53. Manufacturing Process Analysis of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
Figure 54. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
  • Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Growth 2021-2026
    Published: 22-Feb-2021        Price: US 3660 Onwards        Pages: 135
    According to this latest study, the 2020 growth of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors will have significant change from previous year. By the most conservative estimates of global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 8843.8 million in 2019. Over the next five years the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market will register a 2.4% CAGR in terms of revenue, the global market ......
  • Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Research Report 2021
    Published: 19-Feb-2021        Price: US 2900 Onwards        Pages: 94
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Nesina - Tradjenta - Onglyza - Januvia - Others Segment by Application ......
  • Global Insulin Lispro Market Research Report 2021
    Published: 15-Feb-2021        Price: US 2900 Onwards        Pages: 95
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Rapid-acting insulin - Short-acting insulin - Intermediate-acting insulin - Long-acting insulin......
  • 2021 Insulin Market - Size, Share, COVID Impact Analysis and Forecast to 2027
    Published: 14-Feb-2021        Price: US 4580 Onwards        Pages: 115
    2021 Insulin Market - Size, Share, COVID Impact Analysis and Forecast to 2027 - is comprehensive research with in-depth data and contemporary analysis of Insulin Market at a global, regional and key country level, split by different sub-segments of the industry. Insulin Market is quickly reaching its pre-COVID levels and a healthy growth rate is expected over the forecast period driven by the V-shaped recovery in most of the developing nations. Key strategies of com......
  • Global Metformin Hydrochloride Market Growth 2021-2026
    Published: 12-Feb-2021        Price: US 3660 Onwards        Pages: 167
    According to this latest study, the 2020 growth of Metformin Hydrochloride will have significant change from previous year. By the most conservative estimates of global Metformin Hydrochloride market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 249 million in 2019. Over the next five years the Metformin Hydrochloride market will register a 5.7% CAGR in terms of revenue, the global market size will reach US$ 310.9 million by 2025. ......
  • Global Liraglutide Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
    Published: 11-Feb-2021        Price: US 3500 Onwards        Pages: 104
    Based on the Liraglutide market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in deta......
  • Global Glucagon Market Growth 2021-2026
    Published: 11-Feb-2021        Price: US 3660 Onwards        Pages: 138
    According to this latest study, the 2020 growth of Glucagon will have significant change from previous year. By the most conservative estimates of global Glucagon market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 480.9 million in 2019. Over the next five years the Glucagon market will register a 6.3% CAGR in terms of revenue, the global market size will reach US$ 614.7 million by 2025. This report presents a comprehensive overv......
  • Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2021-2026
    Published: 10-Feb-2021        Price: US 3660 Onwards        Pages: 132
    According to this latest study, the 2020 growth of Glucagon Like Peptide-1 (GLP-1) Agonists will have significant change from previous year. By the most conservative estimates of global Glucagon Like Peptide-1 (GLP-1) Agonists market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 6656.5 million in 2019. Over the next five years the Glucagon Like Peptide-1 (GLP-1) Agonists market will register a 13.8% CAGR in terms of revenue, the global market si......
  • Global Antidiabetics Market Research Report 2021
    Published: 10-Feb-2021        Price: US 2900 Onwards        Pages: 97
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Type 1 Diabetes - Type 2 Diabetes - Other Segment by Application - Hospital Use......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs